Publications
Brufsky A, Layman RM, Liu X, Li B, McRoy L, Cohen AB, Estevez M, Cottu P, Curigliano G, Rugo HS. Corrigendum to "Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancer" [The Breast 86 (2026) 104744]. Breast (Edinburgh, Scotland). 2026. PMID: 41936467
Sleeper O, Fortino J, Cho NW, Daud AI, Tsai KK, Lee JC, Alvarado M, Maker AV, Liu L, Kim C, Chan JW. Longitudinal tumor-informed ctDNA monitoring for recurrence and treatment response in melanoma. BMC cancer. 2026. PMID: 41928167
Sleeper O, Fortino J, Cho NW, Daud AI, Tsai KK, Lee JC, Alvarado M, Maker AV, Liu L, Kim C, Chan JW. Longitudinal tumor-informed ctDNA monitoring for recurrence and treatment response in melanoma. BMC cancer. 2026. PMID: 41928167
Nikkilä J, Kumar R, Campbell J, Brandsma I, Pemberton HN, Wallberg F, Nagy K, Scheer I, Vertessy BG, Serebrenik AA, Monni V, Harris RS, Pettitt SJ, Ashworth A, Lord CJ. Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells. British journal of cancer. 2026. PMID: 41699262
Yogo A, Akanuma N, Kim GE, Paciorek A, Zhang L, Le P, Hirose K, Corvera CU, Bergsland EK, Nakakura EK. Characterization of small intestinal neuroendocrine tumorlets. Endocrine-related cancer. 2026. PMID: 41886547
Chang HL, Kang IM, Rugo HS. Eribulin and trastuzumab in early-line HER2-positive metastatic breast cancer: evaluating an active chemotherapy partner in an evolving treatment landscape. Chinese clinical oncology. 2026. PMID: 42145010
Riely GJ, Wood DE, Aisner DL, Axtell AL, Bauman JR, Bharat A, Chang JY, Desai A, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Juloori A, Lackner RP, Lanuti M, Levy B, Lin J, Loo BW, Lovly CM, Maldonado F, Morgensztern D, Mullikin TC, Ng T, Owen D, Owen DH, Patil T, Polanco PM, Riess J, Mendez ALR, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yau E, Yun K, Gregory K, Hang L. Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41956107
Lee G, Haugg F, Bontempi D, He J, Bitterman DS, Pai S, Guthier C, Fitzgerald KJ, Kozono DE, Kann BH, Aerts HJWL, Mak RH. Multimodal Assessment of Biological Age Following Radiation Therapy Among Patients With Early-Stage NSCLC. JAMA network open. 2026. PMID: 41949867
Fann JR, Vanderlan J, Brewer BW, Corbett C, Keller J, Lahijani S, Niazi SK, Riba MB, Andersen B, Atreya CE, Braun I, Breitbart WS, Channa Y, Farabelli J, Fleishman S, Garcia S, Greenberg DB, Handzo RGF, Horyna A, Huang CH, Hutchinson S, Johns S, La Cava S, Leeper H, Martin S, Mukherjee D, Pailler M, Parnes F, Rao V, Rocha-Cadman X, Scher E, Schuster J, Thompson LMA, Usher A, Valentine AD, Montgomery S, Darlow S. NCCN Guidelines® Insights: Distress Management, Version 1.2026. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41956112
Bowers JT, Vijayanarayanan A, Gill N, Traglia M, Thomas R, Andreadis CB, Ai WZ, Ho C, Kaplan LD, Merrill MH, Seshadri MR, Randall MP, Rubenstein JL, Ganapathi K, Prakash S, Devine WP, Spinner MA. CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS). Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41921576
Schwartzberg L, Crawford J, Baird J, Crist K, Marino V, Shah N, Franklin H. CLO26-092: Real-World Use of Eflapegrastim in 14-Day Chemotherapy Cycles/Dose-Dense Regimens. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 42061425
Bowers JT, Vijayanarayanan A, Gill N, Traglia M, Thomas R, Andreadis CB, Ai WZ, Ho C, Kaplan LD, Merrill MH, Seshadri MR, Randall MP, Rubenstein JL, Ganapathi K, Prakash S, Devine WP, Spinner MA. CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS). Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41921576
Walling AM, Sak R, Skootsky S, Wenger N, Balabanova N, Friedberg N, Villalona-Calero M, Schwartz G, Singha S, Bray-Hanin L, Anand S, Jagels B, Dahm L, Cabrera M, Bresnahan A, Meyers B, Sonderlund M, Nelson E, Senthil M, Kane S, Hamdan A, Vu P, Venook A, Burgess D, Gold K. BIO26-035: MTAP Deficiency in Thoracic Oncology: Bridging Genomic Loss, Survival Deficits, and Immunosuppressive Microenvironments. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41911852
Schwartzberg L, Crawford J, Baird J, Crist K, Marino V, Shah N, Franklin H. CLO26-092: Real-World Use of Eflapegrastim in 14-Day Chemotherapy Cycles/Dose-Dense Regimens. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41911759
Bowers JT, Vijayanarayanan A, Gill N, Traglia M, Thomas R, Andreadis CB, Ai WZ, Ho C, Kaplan LD, Merrill MH, Seshadri MR, Randall MP, Rubenstein JL, Ganapathi K, Prakash S, Devine WP, Spinner MA. CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS). Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41921576
Walling AM, Sak R, Skootsky S, Wenger N, Balabanova N, Friedberg N, Villalona-Calero M, Schwartz G, Singha S, Bray-Hanin L, Anand S, Jagels B, Dahm L, Cabrera M, Bresnahan A, Meyers B, Sonderlund M, Nelson E, Senthil M, Kane S, Hamdan A, Vu P, Venook A, Burgess D, Gold K. BIO26-035: Validation of an Electronic Health Record Phenotype for Advanced Solid Cancer Across Five University of California Health Systems. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41991066
Bowers JT, Vijayanarayanan A, Gill N, Traglia M, Thomas R, Andreadis CB, Ai WZ, Ho C, Kaplan LD, Merrill MH, Seshadri MR, Randall MP, Rubenstein JL, Ganapathi K, Prakash S, Devine WP, Spinner MA. CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS). Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41921576
Bowers JT, Vijayanarayanan A, Gill N, Traglia M, Thomas R, Andreadis CB, Ai WZ, Ho C, Kaplan LD, Merrill MH, Seshadri MR, Randall MP, Rubenstein JL, Ganapathi K, Prakash S, Devine WP, Spinner MA. CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS). Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41921576
Rauschecker A, Romano M, Wei J, Girma S, Beheshtian E, Nedelec P, Eghbali R, Sugrue L, Rubenstein JL. YIA26-002: Automated Segmentation and Radiogenomic Analysis of Primary CNS Lymphoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41916413
Rauschecker A, Romano M, Wei J, Girma S, Beheshtian E, Nedelec P, Eghbali R, Sugrue L, Rubenstein JL. YIA26-002: Automated Segmentation and Radiogenomic Analysis of Primary CNS Lymphoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41991092